Literature DB >> 11186442

The ISOLDE trial. Side effects with inhaled steroids should not be forgotten.

B J Lipworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186442      PMCID： PMC1119077     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 2.  Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.

Authors:  B J Lipworth; J R Seckl
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

3.  Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.

Authors:  L Thorsson; K Dahlström; S Edsbäcker; A Källén; J Paulson; J E Wirén
Journal:  Br J Clin Pharmacol       Date:  1997-02       Impact factor: 4.335

4.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

5.  Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma.

Authors:  O Selroos; A B Löfroos; A Pietinalho; H Riska
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

6.  Inhaled corticosteroid use and bone-mineral density in patients with asthma.

Authors:  C A Wong; L J Walsh; C J Smith; A F Wisniewski; S A Lewis; R Hubbard; S Cawte; D J Green; M Pringle; A E Tattersfield
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

7.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

Authors:  B J Lipworth
Journal:  Arch Intern Med       Date:  1999-05-10

8.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Authors:  R A Pauwels; C G Löfdahl; L A Laitinen; J P Schouten; D S Postma; N B Pride; S V Ohlsson
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

9.  Metered dose inhaler induced bronchospasm in asthmatic patients.

Authors:  J Yarbrough; L E Mansfield; S Ting
Journal:  Ann Allergy       Date:  1985-07
  9 in total
  3 in total

1.  Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Authors:  Mathieu Molimard; Pierre-Olivier Girodet; Clothilde Pollet; Annie Fourrier-Réglat; Amélie Daveluy; Françoise Haramburu; Michaël Fayon; Antoine Tabarin
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  The presence of emphysema does not affect the systemic bioactivity of inhaled fluticasone in severe chronic obstructive pulmonary disease.

Authors:  Daniel K C Lee; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

3.  Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Ursula Schild; Erika Süess; Michael Facompre; Florent Baty; Charly Nusbaumer; Martin Brutsche; Beat Müller
Journal:  BMC Pulm Med       Date:  2008-01-26       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.